Sustained response to larotrectinib in a pediatric patient with recurrent STRN3::NTRK2 fusion-positive pilocytic astrocytoma. [PDF]
Balasubramanian K +3 more
europepmc +1 more source
Precision Medicine Program in Chinese Pediatric Patients With Sarcoma. [PDF]
Lu S +29 more
europepmc +1 more source
The role of targetable biomarker alterations in overall survival for non-small cell lung cancer (NSCLC) in a large integrated health system. [PDF]
Jarrin Lopez A +8 more
europepmc +1 more source
A tailored histology-driven molecular profiling algorithm proposal for salivary gland cancers. [PDF]
Alfieri S +21 more
europepmc +1 more source
Reigniting the Flame for Redifferentiation Strategies in Differentiated Thyroid Cancers: Journey of Tyrosine Kinase Inhibitors to Renewed Radioactive-Iodine Avidity. [PDF]
Oh JM, Zhu L, Ahn BC.
europepmc +1 more source
Case Report: Two cases of non-small cell lung cancer with coexistence of <i>NTRK2</i> fusion and <i>EGFR</i> mutations. [PDF]
Zhang Y, Zhang H, Li X.
europepmc +1 more source
Role of NTRK Fusion Genes in the Tumor Immune Microenvironment of HPV (+/-) Cervical Cancer. [PDF]
Wang Q +7 more
europepmc +1 more source
Neurotrophin NGF/TrkA and BDNF/TrkB signaling orchestrates the immune microenvironment in osteosarcoma. [PDF]
Liu H +6 more
europepmc +1 more source
A phase II trial of larotrectinib in tumors with NTRK fusions or extremes of NTRK mRNA overexpression identified by comprehensive genomic profiling. [PDF]
Thavaneswaran S +12 more
europepmc +1 more source

